IMMUNOSENS Co. Ltd. announced that it has received a round of funding on July 26, 2023. The transaction included participation from new investor, Shimadzu Future Innovation Fund L.P., a fund co-managed by Global Brain Co., Ltd., and Shimadzu Corporation.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,376 JPY | +0.97% | +1.37% | +11.01% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.01% | 8.21B | |
-3.44% | 4.68B | |
-6.68% | 2.92B | |
+5.74% | 2.15B | |
-24.56% | 1.15B | |
-3.83% | 889M | |
-18.93% | 798M | |
-8.47% | 806M | |
-57.05% | 681M | |
-23.40% | 684M |
- Stock Market
- Equities
- 7701 Stock
- News Shimadzu Corporation
- IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation